Form 4: National Healthcare Corp CEO Exercises Stock Options, Disposes of Shares for Tax Obligations
SEC Form 4 Filing
CEO Stephen F. Flatt exercised stock options and disposed of shares to cover exercise price and tax obligations, according to a recent SEC filing.
Summary
- On May 17, 2024, Stephen F. Flatt, CEO of National Healthcare Corp, exercised stock options to acquire 2,500 shares of common stock at a price of $53.94 per share.
- Flatt then disposed of 1,776 shares to cover the exercise price and withholding tax obligations at a price of $100.4.
- Following these transactions, Flatt directly owns 60,949 shares of National Healthcare Corp common stock.
- Flatt also holds options to purchase 10,000 shares at $53.94, and options to purchase 15,000 shares at $94.1.
Sentiment
Score: 5
Explanation: The filing is a standard disclosure of insider transactions and doesn't inherently indicate positive or negative sentiment. It's a neutral event in the context of company performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings in the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The exercise of stock options and subsequent sale of shares to cover taxes is a common practice among executives in publicly traded companies.
- Comparing Flatt's holdings and option exercises to those of CEOs at similar healthcare companies (e.g., Brookdale Senior Living, LifePoint Health) would provide a benchmark for assessing the magnitude of his stake and compensation.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may view the exercise of options and subsequent sale of shares as a routine part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date of option grant with exercise price of $63.96 and expiration date of 02/18/2027 |
| 03/08/2023 | Date of option grant with exercise price of $53.94 and expiration date of 03/08/2028 |
| 03/05/2025 | Date of option grant with exercise price of $94.1 and expiration date of 03/05/2029 |
| 05/17/2024 | CEO exercised stock options and disposed of shares. |
| 05/21/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.